EAN 2024 | Predicting clinical outcomes of patients with Parkinson’s who received deep brain stimulation

Anastasia Bougea, PhD, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece, briefly discusses a study involving 35 patients with Parkinson’s disease (PD) undergoing deep brain stimulation (DBS), examining which clinical factors using validated scales could be used to predict motor outcomes two years post-implementation. She also emphasizes the importance of integrating artificial intelligence (AI) tools and biomarkers into studies to improve personalized treatment and outcome prediction for patients. This interview took place at the European Academy of Neurology (EAN) Annual Meeting 2024 in Helsinki, Finland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.